family_id
int64
1
1.1k
family_type
stringclasses
9 values
family_name
stringclasses
590 values
target_id
int64
1
3.29k
target_name
stringlengths
3
122
ligand_id
int64
1
13.4k
ligand_name
stringlengths
2
141
ligand_type
stringclasses
6 values
interaction_id
int64
1
90.9k
interaction_type
stringclasses
11 values
interaction_action
stringclasses
25 values
ligand_approved
bool
2 classes
ligand_approval_source
stringclasses
440 values
ligand_pubchem_sid
float64
53.8M
491M
interaction_primary_target
bool
2 classes
interaction_affinity_median
float64
0.3
13
interaction_affinity_units
stringclasses
7 values
reference_id
float64
21
47.8k
reference_type
stringclasses
4 values
reference_title
stringclasses
714 values
reference_article_title
stringlengths
0
409
reference_pubmed_id
float64
156k
38.9M
reference_doi
stringclasses
154 values
reference_pmc_id
stringlengths
7
11
102
nhr
0B. DAX-like receptors
636
SHP
8,838
compound 10 [PMID: 18759424]
Synthetic organic
82,888
None
Binding
false
252,827,495
false
6.3
pIC50
29,925
Journal
J Med Chem
Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containing protein tyrosine phosphatase-2 activity.
18,759,424
null
PMC4097887
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,885
isocitrate dehydrogenase (NADP(+)) 2
8,960
enasidenib
Synthetic organic
83,689
Inhibitor
Binding
true
FDA (2017)
310,264,741
false
null
-
30,371
Patent
null
Therapeutically active compounds and their methods of use.
null
null
null
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,885
isocitrate dehydrogenase (NADP(+)) 2
12,340
LY3410738
Synthetic organic
89,098
Inhibitor
Inhibition
false
479,821,131
false
6.05
pIC50
44,570
Patent
null
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors
null
null
null
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,885
isocitrate dehydrogenase (NADP(+)) 2
10,663
vorasidenib
Synthetic organic
87,066
Inhibitor
Inhibition
false
404,859,110
false
null
-
38,752
Journal
ACS Med Chem Lett
Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma.
32,071,674
10.1021/acsmedchemlett.9b00509
null
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,884
isocitrate dehydrogenase (NADP(+)) 1
9,217
ivosidenib
Synthetic organic
83,688
Inhibitor
Inhibition
true
FDA (2018), EMA (2023)
315,661,293
true
null
-
31,205
Patent
null
Therapeutically active compounds and their methods of use
null
null
null
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,884
isocitrate dehydrogenase (NADP(+)) 1
12,340
LY3410738
Synthetic organic
89,097
Inhibitor
Inhibition
false
479,821,131
false
8.2
pIC50
44,570
Patent
null
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors
null
null
null
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,884
isocitrate dehydrogenase (NADP(+)) 1
9,240
AGI-5198
Synthetic organic
83,752
Inhibitor
Inhibition
false
315,661,315
true
4.89
pKi
null
null
null
null
null
null
null
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,884
isocitrate dehydrogenase (NADP(+)) 1
12,340
LY3410738
Synthetic organic
89,096
Inhibitor
Inhibition
false
479,821,131
false
6.98
pIC50
44,570
Patent
null
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors
null
null
null
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,884
isocitrate dehydrogenase (NADP(+)) 1
10,319
olutasidenib
Synthetic organic
86,199
Inhibitor
Inhibition
true
FDA (2022)
381,745,000
false
null
pIC50
37,387
Patent
null
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
null
null
null
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,884
isocitrate dehydrogenase (NADP(+)) 1
11,884
safusidenib
Synthetic organic
88,488
Inhibitor
Inhibition
false
461,663,440
false
6.89
pIC50
43,349
Journal
Mol Cancer Ther
A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model.
31,727,689
null
922
enzyme
1.1.1.42 Isocitrate dehydrogenases
2,884
isocitrate dehydrogenase (NADP(+)) 1
10,663
vorasidenib
Synthetic organic
87,065
Inhibitor
Inhibition
false
404,859,110
false
null
-
38,752
Journal
ACS Med Chem Lett
Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma.
32,071,674
10.1021/acsmedchemlett.9b00509
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
9,019
navoximod
Synthetic organic
83,385
Inhibitor
Inhibition
false
315,661,104
false
8.24
pKi
38,078
Journal
J Med Chem
Discovery of Clinical Candidate (1<i>R</i>,4<i>r</i>)-4-((<i>R</i>)-2-((<i>S</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1.
31,264,862
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
9,750
necrostatin-1
Synthetic organic
84,754
Inhibitor
Inhibition
false
354,702,223
false
4.94
pKi
34,030
Journal
Nat Med
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.
15,711,557
null
null
899
enzyme
1.13.11.- Dioxygenases
3,019
indoleamine 2,3-dioxygenase 2
10,126
tryptanthrin 5i
Synthetic organic
85,686
Inhibitor
Inhibition
false
381,118,836
false
5.74
pIC50
36,340
Journal
Eur J Med Chem
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
27,475,108
null
899
enzyme
1.13.11.- Dioxygenases
3,019
indoleamine 2,3-dioxygenase 2
10,126
tryptanthrin 5i
Synthetic organic
85,685
Inhibitor
Inhibition
false
381,118,836
false
6.01
pKi
36,340
Journal
Eur J Med Chem
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
27,475,108
null
899
enzyme
1.13.11.- Dioxygenases
3,019
indoleamine 2,3-dioxygenase 2
12,668
example 184 [WO2014186035]
Synthetic organic
89,777
Inhibitor
Inhibition
false
483,123,216
false
6
pIC50
45,531
Patent
null
Inhibitors of the kynurenine pathway
null
null
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
10,126
tryptanthrin 5i
Synthetic organic
85,689
Inhibitor
Inhibition
false
381,118,836
false
6.99
pIC50
36,340
Journal
Eur J Med Chem
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
27,475,108
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
10,126
tryptanthrin 5i
Synthetic organic
85,688
Inhibitor
Inhibition
false
381,118,836
false
7.27
pKi
36,340
Journal
Eur J Med Chem
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
27,475,108
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
8,224
tryptanthrin
Natural product
81,828
Inhibitor
Inhibition
false
249,565,904
false
5.32
pKi
27,057
Journal
J Med Chem
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
24,099,220
null
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
9,565
PF-06840003
Synthetic organic
84,344
Inhibitor
Inhibition
false
336,446,951
false
6.82
pIC50
33,072
Patent
null
Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors.
null
null
null
899
enzyme
1.13.11.- Dioxygenases
2,887
tryptophan 2,3-dioxygenase
9,019
navoximod
Synthetic organic
86,538
Inhibitor
Inhibition
false
315,661,104
false
6
pIC50
35,557
Journal
J Med Chem
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
26,207,924
null
899
enzyme
1.13.11.- Dioxygenases
2,887
tryptophan 2,3-dioxygenase
9,016
LM10
Synthetic organic
83,380
Inhibitor
Inhibition
false
315,661,101
true
5.25
pKi
30,562
Journal
Proc Natl Acad Sci USA
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.
22,308,364
null
PMC3289319
899
enzyme
1.13.11.- Dioxygenases
2,887
tryptophan 2,3-dioxygenase
9,016
LM10
Synthetic organic
83,381
Inhibitor
Inhibition
false
315,661,101
true
6.21
pIC50
30,562
Journal
Proc Natl Acad Sci USA
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.
22,308,364
null
PMC3289319
899
enzyme
1.13.11.- Dioxygenases
2,887
tryptophan 2,3-dioxygenase
9,016
LM10
Synthetic organic
83,382
Inhibitor
Inhibition
false
315,661,101
false
5.71
pIC50
30,562
Journal
Proc Natl Acad Sci USA
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.
22,308,364
null
PMC3289319
899
enzyme
1.13.11.- Dioxygenases
2,887
tryptophan 2,3-dioxygenase
9,016
LM10
Synthetic organic
83,380
Inhibitor
Inhibition
false
315,661,101
true
5.25
pKi
30,563
Journal
J Med Chem
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
21,726,069
null
null
899
enzyme
1.13.11.- Dioxygenases
3,019
indoleamine 2,3-dioxygenase 2
10,126
tryptanthrin 5i
Synthetic organic
85,687
Inhibitor
Inhibition
false
381,118,836
false
6.35
pIC50
36,340
Journal
Eur J Med Chem
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
27,475,108
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
8,225
1-methyl-L-tryptophan
Synthetic organic
81,829
Inhibitor
Inhibition
false
249,565,905
false
4.37
pKi
27,057
Journal
J Med Chem
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
24,099,220
null
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
8,227
amg-1
Synthetic organic
81,830
Inhibitor
Inhibition
false
249,565,907
false
5.52
pIC50
27,060
Journal
Biochim Biophys Acta
Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors.
21,835,273
null
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
8,222
beta-carboline
Synthetic organic
81,831
Inhibitor
Inhibition
false
249,565,902
false
0.92
pKi
27,062
Journal
Bioorg Med Chem
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
21,269,836
null
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
10,682
compound 8u [PMID: 31999451]
Synthetic organic
87,100
Inhibitor
Inhibition
false
404,859,129
false
7.1
pKd
38,829
Journal
J Med Chem
Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3.
31,999,451
null
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
8,221
epacadostat
Synthetic organic
81,826
Inhibitor
Inhibition
false
249,565,901
true
7.17
pIC50
27,054
Journal
J Med Chem
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
19,507,862
null
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
9,707
linrodostat
Synthetic organic
87,102
Inhibitor
Inhibition
false
348,353,666
false
null
-
38,831
Journal
Proc Natl Acad Sci USA
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.
29,531,094
null
899
enzyme
1.13.11.- Dioxygenases
2,829
indoleamine 2,3-dioxygenase 1
9,940
LW106
Synthetic organic
85,196
Inhibitor
Inhibition
false
363,894,234
false
5.8
pIC50
35,001
Journal
Br J Pharmacol
LW106, a novel indoleamine 2,3-dioxygenase 1 inhibitor, suppresses tumour progression by limiting stroma-immune crosstalk and cancer stem cell enrichment in tumour micro-environment.
29,722,898
null
PMC6016675
869
enzyme
1.14.11.- Histone demethylases
2,673
lysine demethylase 3A
8,230
IOX1
Synthetic organic
81,840
Inhibitor
Inhibition
false
249,565,910
true
7
pIC50
27,117
Journal
ChemMedChem
A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.
24,504,543
null
PMC4503230
869
enzyme
1.14.11.- Histone demethylases
2,671
lysine demethylase 2A
8,229
IOX2
Synthetic organic
81,838
Inhibitor
Inhibition
false
249,565,909
false
7.28
pIC50
27,116
Journal
ACS Chem Biol
Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
23,683,440
null
null
869
enzyme
1.14.11.- Histone demethylases
2,671
lysine demethylase 2A
7,025
daminozide
Synthetic organic
79,347
Inhibitor
Inhibition
false
178,103,604
false
5.82
pIC50
24,165
Journal
J Med Chem
Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.
22,724,510
null
PMC4673902
869
enzyme
1.14.11.- Histone demethylases
2,669
lysine demethylase 1A
5,281
tranylcypromine
Synthetic organic
80,056
Inhibitor
Inhibition
true
FDA (1961)
178,101,964
false
4.4
pIC50
24,161
Journal
MBio
A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.
23,386,436
null
PMC3565832
869
enzyme
1.14.11.- Histone demethylases
2,669
lysine demethylase 1A
11,516
TAK-418
Synthetic organic
87,987
Inhibitor
Inhibition
false
441,604,888
false
8.54
pIC50
41,977
Journal
Sci Adv
LSD1 enzyme inhibitor TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models.
33,712,455
10.1126/sciadv.aba1187
null
869
enzyme
1.14.11.- Histone demethylases
2,669
lysine demethylase 1A
8,980
RN-1
Synthetic organic
83,295
Inhibitor
Inhibition
false
310,264,760
true
null
pIC50
30,419
Journal
ACS Chem Neurosci
Brain-penetrant LSD1 inhibitors can block memory consolidation.
22,754,608
null
PMC3382965
869
enzyme
1.14.11.- Histone demethylases
2,669
lysine demethylase 1A
8,390
ORY-1001
Synthetic organic
84,267
Activator
Activation
false
252,166,601
true
7.7
pIC50
32,716
Journal
Epigenomics
KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.
26,111,032
null
null
869
enzyme
1.14.11.- Histone demethylases
2,669
lysine demethylase 1A
7,024
NCL-1
Synthetic organic
79,345
Inhibitor
Inhibition
false
178,103,603
false
5.8
pIC50
24,162
Journal
Bioorg Med Chem
Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor.
21,227,703
null
null
869
enzyme
1.14.11.- Histone demethylases
2,669
lysine demethylase 1A
8,241
GSK-LSD1
Synthetic organic
81,857
Inhibitor
Inhibition
false
249,565,921
true
7.8
pIC50
27,143
Webpage
null
GSK-LSD1 - a chemical probe for LSD1.
null
null
869
enzyme
1.14.11.- Histone demethylases
2,669
lysine demethylase 1A
9,116
GSK2879552
Synthetic organic
83,517
Inhibitor
Inhibition
false
315,661,201
false
6.4
pIC50
30,869
Patent
null
Cyclopropylamines as lsd1 inhibitors
null
null
null
869
enzyme
1.14.11.- Histone demethylases
2,669
lysine demethylase 1A
11,284
CC-90011
Synthetic organic
87,625
Inhibitor
Inhibition
false
434,321,719
false
9.52
pIC50
40,730
Journal
J Med Chem
Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)
33,034,194
10.1021/acs.jmedchem.0c00978
null
869
enzyme
1.14.11.- Histone demethylases
2,669
lysine demethylase 1A
7,023
OG-L002
Synthetic organic
80,055
Inhibitor
Inhibition
false
178,103,602
false
7.7
pIC50
24,161
Journal
MBio
A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.
23,386,436
null
PMC3565832
869
enzyme
1.14.11.- Histone demethylases
2,698
PHD finger protein 8
7,025
daminozide
Synthetic organic
79,346
Inhibitor
Inhibition
false
178,103,604
false
6.26
pIC50
24,165
Journal
J Med Chem
Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.
22,724,510
null
PMC4673902
869
enzyme
1.14.11.- Histone demethylases
2,686
lysine demethylase 7A
7,025
daminozide
Synthetic organic
79,348
Inhibitor
Inhibition
false
178,103,604
false
5.68
pIC50
24,165
Journal
J Med Chem
Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.
22,724,510
null
PMC4673902
869
enzyme
1.14.11.- Histone demethylases
2,685
lysine demethylase 6B
12,807
zavondemstat
Synthetic organic
89,918
Inhibitor
Inhibition
false
483,123,355
false
null
pIC50
45,828
Patent
null
Histone demethylase inhibitors
null
null
null
869
enzyme
1.14.11.- Histone demethylases
2,685
lysine demethylase 6B
8,230
IOX1
Synthetic organic
81,842
Inhibitor
Inhibition
false
249,565,910
false
5.8
pIC50
27,117
Journal
ChemMedChem
A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.
24,504,543
null
PMC4503230
869
enzyme
1.14.11.- Histone demethylases
2,685
lysine demethylase 6B
8,979
GSK-J4
Synthetic organic
83,289
Inhibitor
Inhibition
false
310,264,759
false
5.07
pIC50
30,418
Journal
Nature
Inhibition of demethylases by GSK-J1/J4.
25,279,926
null
null
869
enzyme
1.14.11.- Histone demethylases
2,685
lysine demethylase 6B
7,027
GSK-J1
Synthetic organic
79,352
Inhibitor
Inhibition
false
178,103,606
false
null
pIC50
24,169
Journal
Nature
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.
22,842,901
null
PMC4691848
869
enzyme
1.14.11.- Histone demethylases
2,685
lysine demethylase 6B
7,027
GSK-J1
Synthetic organic
79,352
Inhibitor
Inhibition
false
178,103,606
false
null
pIC50
30,418
Journal
Nature
Inhibition of demethylases by GSK-J1/J4.
25,279,926
null
null
869
enzyme
1.14.11.- Histone demethylases
2,685
lysine demethylase 6B
9,960
compound 3 [PMID: 29633584]
Synthetic organic
85,227
Inhibitor
Inhibition
false
374,883,847
true
5.82
pIC50
35,098
Journal
ChemMedChem
Virtual Fragment Screening Identification of a Quinoline-5,8-dicarboxylic Acid Derivative as a Selective JMJD3 Inhibitor.
29,633,584
null
PMC6055880
869
enzyme
1.14.11.- Histone demethylases
2,684
lysine demethylase 6A
10,141
KDM5 inhibitor N71
Synthetic organic
85,721
Inhibitor
Inhibition
false
381,118,851
false
4.22
pIC50
36,398
Journal
J Med Chem
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.
30,392,349
null
PMC6467790
869
enzyme
1.14.11.- Histone demethylases
2,684
lysine demethylase 6A
8,979
GSK-J4
Synthetic organic
83,288
Inhibitor
Inhibition
false
310,264,759
false
5.18
pIC50
30,418
Journal
Nature
Inhibition of demethylases by GSK-J1/J4.
25,279,926
null
null
869
enzyme
1.14.11.- Histone demethylases
2,684
lysine demethylase 6A
7,027
GSK-J1
Synthetic organic
83,287
Inhibitor
Inhibition
false
178,103,606
false
7.28
pIC50
30,418
Journal
Nature
Inhibition of demethylases by GSK-J1/J4.
25,279,926
null
null
869
enzyme
1.14.11.- Histone demethylases
2,682
lysine demethylase 5C
7,026
PBIT
Synthetic organic
79,351
Inhibitor
Inhibition
false
178,103,605
false
5.31
pIC50
24,166
Journal
J Biol Chem
Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
23,408,432
null
PMC3611010
869
enzyme
1.14.11.- Histone demethylases
2,682
lysine demethylase 5C
8,229
IOX2
Synthetic organic
81,839
Inhibitor
Inhibition
false
249,565,909
false
6.8
pIC50
27,116
Journal
ACS Chem Biol
Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
23,683,440
null
null
869
enzyme
1.14.11.- Histone demethylases
2,682
lysine demethylase 5C
8,979
GSK-J4
Synthetic organic
83,294
Inhibitor
Inhibition
false
310,264,759
false
4.82
pIC50
30,418
Journal
Nature
Inhibition of demethylases by GSK-J1/J4.
25,279,926
null
null
869
enzyme
1.14.11.- Histone demethylases
2,682
lysine demethylase 5C
7,027
GSK-J1
Synthetic organic
83,293
Inhibitor
Inhibition
false
178,103,606
false
6.26
pIC50
30,418
Journal
Nature
Inhibition of demethylases by GSK-J1/J4.
25,279,926
null
null
869
enzyme
1.14.11.- Histone demethylases
2,681
lysine demethylase 5B
7,026
PBIT
Synthetic organic
79,349
Inhibitor
Inhibition
false
178,103,605
false
5.52
pIC50
24,166
Journal
J Biol Chem
Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
23,408,432
null
PMC3611010
869
enzyme
1.14.11.- Histone demethylases
2,681
lysine demethylase 5B
8,576
KDOAM25
Synthetic organic
89,969
Inhibitor
Inhibition
false
252,166,777
false
7.72
pIC50
45,914
Journal
Cell Chem Biol
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.
28,262,558
null
869
enzyme
1.14.11.- Histone demethylases
2,681
lysine demethylase 5B
10,141
KDM5 inhibitor N71
Synthetic organic
85,719
Inhibitor
Irreversible inhibition
false
381,118,851
true
6.66
pIC50
36,398
Journal
J Med Chem
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.
30,392,349
null
PMC6467790
869
enzyme
1.14.11.- Histone demethylases
2,681
lysine demethylase 5B
8,979
GSK-J4
Synthetic organic
83,292
Inhibitor
Inhibition
false
310,264,759
false
5.01
pIC50
30,418
Journal
Nature
Inhibition of demethylases by GSK-J1/J4.
25,279,926
null
null
869
enzyme
1.14.11.- Histone demethylases
2,681
lysine demethylase 5B
7,027
GSK-J1
Synthetic organic
83,291
Inhibitor
Inhibition
false
178,103,606
false
6.77
pIC50
30,418
Journal
Nature
Inhibition of demethylases by GSK-J1/J4.
25,279,926
null
null
869
enzyme
1.14.11.- Histone demethylases
2,681
lysine demethylase 5B
10,083
Compound 9 [doi:10.26434/chemrxiv.7072592.v1]
Synthetic organic
85,544
Inhibitor
Inhibition
false
375,973,270
true
6.52
pIC50
36,158
Journal
Angew Chem Int Ed Engl
Design, Synthesis and Characterization of Covalent KDM5 Inhibitors.
30,431,220
10.26434/chemrxiv.7072592.v1
null
869
enzyme
1.14.11.- Histone demethylases
2,680
lysine demethylase 5A
7,026
PBIT
Synthetic organic
79,350
Inhibitor
Inhibition
false
178,103,605
false
5.22
pIC50
24,166
Journal
J Biol Chem
Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
23,408,432
null
PMC3611010
869
enzyme
1.14.11.- Histone demethylases
2,680
lysine demethylase 5A
10,141
KDM5 inhibitor N71
Synthetic organic
85,718
Inhibitor
Irreversible inhibition
false
381,118,851
true
6.49
pIC50
36,398
Journal
J Med Chem
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.
30,392,349
null
PMC6467790
869
enzyme
1.14.11.- Histone demethylases
2,680
lysine demethylase 5A
7,027
GSK-J1
Synthetic organic
83,290
Inhibitor
Inhibition
false
178,103,606
false
5.17
pIC50
30,418
Journal
Nature
Inhibition of demethylases by GSK-J1/J4.
25,279,926
null
null
869
enzyme
1.14.11.- Histone demethylases
2,679
lysine demethylase 4E
9,584
ML324
Synthetic organic
84,387
Inhibitor
Inhibition
false
340,590,215
false
6.04
pIC50
33,194
Journal
Probe Reports from the NIH Molecular Libraries Program
Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity
24,260,783
null
null
869
enzyme
1.14.11.- Histone demethylases
2,679
lysine demethylase 4E
8,744
compound 6a [PMID: 18942826]
Synthetic organic
82,695
Inhibitor
Inhibition
false
252,827,402
false
5.85
pIC50
29,703
Journal
J Med Chem
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
18,942,826
null
null
869
enzyme
1.14.11.- Histone demethylases
2,677
lysine demethylase 4C
12,807
zavondemstat
Synthetic organic
89,917
Inhibitor
Inhibition
false
483,123,355
false
null
pIC50
45,828
Patent
null
Histone demethylase inhibitors
null
null
null
869
enzyme
1.14.11.- Histone demethylases
2,677
lysine demethylase 4C
8,230
IOX1
Synthetic organic
81,841
Inhibitor
Inhibition
false
249,565,910
false
6.22
pIC50
27,117
Journal
ChemMedChem
A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.
24,504,543
null
PMC4503230
869
enzyme
1.14.11.- Histone demethylases
2,675
lysine demethylase 4A
9,584
ML324
Synthetic organic
84,388
Inhibitor
Inhibition
false
340,590,215
false
6
pIC50
33,194
Journal
Probe Reports from the NIH Molecular Libraries Program
Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity
24,260,783
null
null
869
enzyme
1.14.11.- Histone demethylases
2,675
lysine demethylase 4A
10,141
KDM5 inhibitor N71
Synthetic organic
85,720
Inhibitor
Inhibition
false
381,118,851
false
5.28
pIC50
36,398
Journal
J Med Chem
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.
30,392,349
null
PMC6467790
869
enzyme
1.14.11.- Histone demethylases
2,675
lysine demethylase 4A
8,744
compound 6a [PMID: 18942826]
Synthetic organic
82,694
Inhibitor
Inhibition
false
252,827,402
false
6.15
pIC50
29,703
Journal
J Med Chem
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
18,942,826
null
null
923
enzyme
1.14.13.9 Kynurenine 3-monooxygenase
2,886
kynurenine 3-monooxygenase
10,358
GSK065
Synthetic organic
86,320
Inhibitor
Inhibition
false
384,403,639
false
10.3
pKi
37,581
Journal
Nat Commun
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase.
28,604,669
PMC5477544
923
enzyme
1.14.13.9 Kynurenine 3-monooxygenase
2,886
kynurenine 3-monooxygenase
10,358
GSK065
Synthetic organic
86,319
Inhibitor
Inhibition
false
384,403,639
false
8.6
pIC50
37,581
Journal
Nat Commun
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase.
28,604,669
PMC5477544
923
enzyme
1.14.13.9 Kynurenine 3-monooxygenase
2,886
kynurenine 3-monooxygenase
9,007
GSK180
Synthetic organic
83,368
Inhibitor
Inhibition
false
310,264,785
true
8.2
pIC50
30,503
Journal
Nat Med
Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis.
26,752,518
null
PMC4871268
877
enzyme
1.17.4.1 Ribonucleoside-diphosphate reductases
2,630
ribonucleotide reductase catalytic subunit M1
6,802
clofarabine
Synthetic organic
78,910
Inhibitor
Inhibition
true
FDA (2004), EMA (2009)
178,103,408
false
8.3
pIC50
23,352
Journal
Cancer Res
Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
1,707,752
null
null
877
enzyme
1.17.4.1 Ribonucleoside-diphosphate reductases
2,630
ribonucleotide reductase catalytic subunit M1
4,802
fludarabine
Synthetic organic
78,912
Inhibitor
Inhibition
true
FDA (1991)
178,101,504
true
6
pIC50
23,353
Journal
Mol Pharmacol
In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
7,048,062
null
null
877
enzyme
1.17.4.1 Ribonucleoside-diphosphate reductases
2,630
ribonucleotide reductase catalytic subunit M1
4,793
gemcitabine
Synthetic organic
78,905
Inhibitor
Inhibition
true
FDA (1996)
178,101,495
true
null
-
23,348
Journal
Mol Pharmacol
Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.
2,233,693
null
null
877
enzyme
1.17.4.1 Ribonucleoside-diphosphate reductases
2,630
ribonucleotide reductase catalytic subunit M1
6,822
hydroxyurea
Synthetic organic
78,907
Inhibitor
Inhibition
true
FDA (1967), EMA (2007)
178,103,428
true
3.83
pIC50
23,349
Journal
Biochem Pharmacol
Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay.
15,670,581
null
null
877
enzyme
1.17.4.1 Ribonucleoside-diphosphate reductases
2,630
ribonucleotide reductase catalytic subunit M1
12,113
TAS1553
Synthetic organic
88,838
Inhibitor
Binding
false
472,319,235
false
7.46
pKd
43,979
Journal
Commun Biol
TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress.
35,681,099
null
877
enzyme
1.17.4.1 Ribonucleoside-diphosphate reductases
2,631
ribonucleotide reductase regulatory subunit M2
6,802
clofarabine
Synthetic organic
78,911
Inhibitor
Inhibition
true
FDA (2004), EMA (2009)
178,103,408
true
8.3
pIC50
23,352
Journal
Cancer Res
Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
1,707,752
null
null
877
enzyme
1.17.4.1 Ribonucleoside-diphosphate reductases
2,631
ribonucleotide reductase regulatory subunit M2
4,802
fludarabine
Synthetic organic
78,913
Inhibitor
Inhibition
true
FDA (1991)
178,101,504
true
6
pIC50
23,353
Journal
Mol Pharmacol
In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
7,048,062
null
null
877
enzyme
1.17.4.1 Ribonucleoside-diphosphate reductases
2,631
ribonucleotide reductase regulatory subunit M2
4,793
gemcitabine
Synthetic organic
78,906
Inhibitor
Inhibition
true
FDA (1996)
178,101,495
true
null
-
23,348
Journal
Mol Pharmacol
Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.
2,233,693
null
null
877
enzyme
1.17.4.1 Ribonucleoside-diphosphate reductases
2,631
ribonucleotide reductase regulatory subunit M2
6,822
hydroxyurea
Synthetic organic
78,908
Inhibitor
Inhibition
true
FDA (1967), EMA (2007)
178,103,428
true
3.83
pIC50
23,349
Journal
Biochem Pharmacol
Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay.
15,670,581
null
null
1,068
enzyme
1.2.3.1 Aldehyde oxidase
3,186
aldehyde oxidase 1
2,820
raloxifene
Synthetic organic
89,776
Inhibitor
Inhibition
true
FDA (1997), EMA (1998)
135,650,883
false
7.35
pIC50
45,530
Patent
null
Therapeutic agent for nonalcoholic fatty liver disease
null
null
null
912
enzyme
1.4.3.13 Lysyl oxidases
3,097
lysyl oxidase
10,485
CCT365623
Synthetic organic
86,766
Inhibitor
Inhibition
false
385,612,244
false
6.05
pIC50
38,259
Journal
J Med Chem
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships.
31,070,916
null
912
enzyme
1.4.3.13 Lysyl oxidases
3,097
lysyl oxidase
10,486
compound 21b [PMID: 31430136]
Synthetic organic
86,767
Inhibitor
Inhibition
false
385,612,245
false
5.48
pIC50
38,256
Journal
J Med Chem
2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth.
31,430,136
null
PMC7073924
912
enzyme
1.4.3.13 Lysyl oxidases
2,853
lysyl oxidase like 2
10,485
CCT365623
Synthetic organic
86,768
Inhibitor
Inhibition
false
385,612,244
false
5.82
pIC50
38,259
Journal
J Med Chem
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships.
31,070,916
null
912
enzyme
1.4.3.13 Lysyl oxidases
2,853
lysyl oxidase like 2
10,486
compound 21b [PMID: 31430136]
Synthetic organic
86,769
Inhibitor
Inhibition
false
385,612,245
true
6.82
pIC50
38,256
Journal
J Med Chem
2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth.
31,430,136
null
PMC7073924
912
enzyme
1.4.3.13 Lysyl oxidases
2,853
lysyl oxidase like 2
8,412
simtuzumab
Antibody
82,117
Inhibitor
Inhibition
false
252,166,622
true
7.17
pKi
27,880
Patent
null
LOX and LOXL2 inhibitors and uses thereof.
null
null
null
84
nhr
1A. Thyroid hormone receptors
588
Thyroid hormone receptor-&alpha;
2,639
sobetirome
Synthetic organic
6,262
Agonist
Agonist
false
135,650,297
null
9.36
pKd
10,040
Journal
Mol Endocrinol
Binding of 3,5,3'-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the alpha- and beta-forms for the acetic acid analog and failure of the human testis and kidney alpha-2 products to bind T3.
2,158,622
null
null
84
nhr
1A. Thyroid hormone receptors
588
Thyroid hormone receptor-&alpha;
2,636
rT<sub>3</sub>
Synthetic organic
6,260
Agonist
Agonist
false
135,650,897
null
null
pIC50
10,040
Journal
Mol Endocrinol
Binding of 3,5,3'-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the alpha- and beta-forms for the acetic acid analog and failure of the human testis and kidney alpha-2 products to bind T3.
2,158,622
null
null
84
nhr
1A. Thyroid hormone receptors
588
Thyroid hormone receptor-&alpha;
12,026
resmetirom
Synthetic organic
88,707
Agonist
Agonist
true
FDA (2024)
464,244,167
false
5.43
pEC50
43,758
Journal
J Med Chem
Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia.
24,712,661
null
84
nhr
1A. Thyroid hormone receptors
588
Thyroid hormone receptor-&alpha;
2,633
NH-3
Synthetic organic
6,257
Antagonist
Antagonist
false
135,650,713
null
7.62
pKd
10,041
Journal
J Med Chem
Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.
12,109,914
null
null
84
nhr
1A. Thyroid hormone receptors
588
Thyroid hormone receptor-&alpha;
2,638
KB-141
Synthetic organic
6,263
Agonist
Agonist
false
135,650,452
null
7.6
pIC50
10,066
Journal
J Med Chem
Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
12,699,376
null
null
84
nhr
1A. Thyroid hormone receptors
588
Thyroid hormone receptor-&alpha;
6,951
dextrothyroxine
Synthetic organic
79,001
Agonist
Agonist
true
FDA (1967)
178,103,533
true
null
-
23,507
Journal
J Clin Endocrinol Metab
Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults.
6,777,394
null
null

Dataset Card for dwb2023/family-target-interaction-ligand-gtopdb

Dataset Details

Dataset Description

Dataset created using the IUPHAR database from the Guide to Pharmacology website

Dataset Sources

Dataset Creation

Source Data

Query used to create the dataset:

 SELECT f.family_id,
    f.type AS family_type,
    f.name AS family_name,
    o.object_id AS target_id,
    o.name AS target_name,
    l.ligand_id,
    l.name AS ligand_name,
    l.type AS ligand_type,
    i.interaction_id,
    i.type AS interaction_type,
    i.action AS interaction_action,
    l.approved AS ligand_approved,
    l.approved_source AS ligand_approval_source,
    l.pubchem_sid AS ligand_pubchem_sid,
    i.primary_target AS interaction_primary_target,
    i.affinity_median AS interaction_affinity_median,
    i.affinity_units AS interaction_affinity_units,
    r.reference_id,
    r.type AS reference_type,
    r.title AS reference_title,
    r.article_title AS reference_article_title,
    r.pubmed_id AS reference_pubmed_id,
    r.doi AS reference_doi,
    r.pmc_id AS reference_pmc_id
   FROM object o
     JOIN receptor2family rf ON o.object_id = rf.object_id
     JOIN family f ON rf.family_id = f.family_id
     JOIN interaction i ON o.object_id = i.object_id
     JOIN ligand l ON i.ligand_id = l.ligand_id
     LEFT JOIN interaction_affinity_refs ia ON i.interaction_id = ia.interaction_id
     LEFT JOIN reference r ON ia.reference_id = r.reference_id
  ORDER BY f.type, f.name, o.name, l.name;

Citation

BibTeX:

@article{10.1093/nar/gkad944,
    author = {Harding, Simon D and Armstrong, Jane F and Faccenda, Elena and Southan, Christopher and Alexander, Stephen P H and Davenport, Anthony P and Spedding, Michael and Davies, Jamie A},
    title = "{The IUPHAR/BPS Guide to PHARMACOLOGY in 2024}",
    journal = {Nucleic Acids Research},
    volume = {52},
    number = {D1},
    pages = {D1438-D1449},
    year = {2023},
    month = {10},
    abstract = "{The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb; https://www.guidetopharmacology.org) is an open-access, expert-curated, online database that provides succinct overviews and key references for pharmacological targets and their recommended experimental ligands. It includes over 3039 protein targets and 12 163 ligand molecules, including approved drugs, small molecules, peptides and antibodies. Here, we report recent developments to the resource and describe expansion in content over the six database releases made during the last two years. The database update section of this paper focuses on two areas relating to important global health challenges. The first, SARS-CoV-2 COVID-19, remains a major concern and we describe our efforts to expand the database to include a new family of coronavirus proteins. The second area is antimicrobial resistance, for which we have extended our coverage of antibacterials in partnership with AntibioticDB, a collaboration that has continued through support from GARDP. We discuss other areas of curation and also focus on our external links to resources such as PubChem that bring important synergies to the resources.}",
    issn = {0305-1048},
    doi = {10.1093/nar/gkad944},
    url = {https://doi.org/10.1093/nar/gkad944},
    eprint = {https://academic.oup.com/nar/article-pdf/52/D1/D1438/55039511/gkad944.pdf},
}

Glossary

Here's a glossary for the dataset dwb2023/family_target_ligand_gtopdb based on the dataset description and the SQL query provided:

Glossary

  • family_id: Unique identifier for a family in the IUPHAR database. A family groups related pharmacological targets based on their function or structure.

  • family_type: The classification type of the family. This could refer to the specific category or class the family belongs to within the broader pharmacological context.

  • family_name: The name of the family, which provides a descriptive label for the group of related targets.

  • target_id: Unique identifier for a target in the IUPHAR database. A target is a biological entity, such as a receptor or enzyme, that a ligand interacts with.

  • target_name: The name of the target, describing the specific protein or molecule that a ligand can bind to or influence.

  • interaction_id: A unique identifier for an interaction in the IUPHAR database. An interaction refers to the relationship between a ligand and a target, where the ligand binds to or affects the target in some way.

  • interaction_type: The type of interaction occurring between the ligand and the target. This might describe whether the interaction is inhibitory, stimulatory, or another type of effect that the ligand has on the target.

  • interaction_action: The specific action that the ligand exerts on the target, such as activation, inhibition, modulation, or binding.

  • ligand_id: Unique identifier for a ligand in the IUPHAR database. A ligand is a substance (such as a drug, hormone, or neurotransmitter) that forms a complex with a biomolecule to serve a biological purpose.

  • ligand_name: The name of the ligand, describing the specific molecule that interacts with the target.

  • ligand_type: The classification type of the ligand, which describes the nature of the ligand (e.g., small molecule, peptide, antibody, etc.).

  • ligand_approved: A boolean indicator (True/False) that specifies whether the ligand has been approved by regulatory authorities for therapeutic use.

  • ligand_approval_source: The source or agency that approved the ligand for therapeutic use, such as the FDA (Food and Drug Administration) or EMA (European Medicines Agency).

  • ligand_pubchem_sid: The Substance ID (SID) in the PubChem database, which provides a unique identifier for substances recorded in PubChem. It links to detailed chemical and biological information about the ligand.

  • interaction_primary_target: A boolean indicator (True/False) that specifies whether the target is the primary target for the ligand in the context of the recorded interaction. The primary target is usually the main biological entity that the ligand is designed to influence.

  • interaction_affinity_median: The median value of the affinity data for the interaction, usually expressed as a numerical value that indicates how strongly the ligand binds to the target. Affinity is often measured in terms of concentration, such as in nanomolar (nM) units.

  • interaction_affinity_units: The units in which the affinity of the ligand for the target is measured, such as nanomolar (nM), micromolar (μM), or other relevant concentration units.

  • reference_id: A unique identifier for the reference or source of information about the interaction or ligand in the IUPHAR database.

  • reference_type: The type or category of the reference, which could indicate whether it's a journal article, book, database entry, or another form of scientific literature.

  • reference_title: The full title of the reference, which provides a brief description of the content of the source.

  • reference_article_title: The title of the specific article within a larger publication, if applicable. This may be the same as the reference_title for journal articles.

  • reference_pubmed_id: The unique identifier assigned to the reference in PubMed, a free full-text archive of biomedical and life sciences journal literature. This allows for easy lookup of the reference in the PubMed database.

  • reference_doi: The Digital Object Identifier (DOI) for the reference, which is a persistent and unique identifier for the document that allows for reliable linking to its online location.

  • reference_pmc_id: The unique identifier for the reference in PubMed Central (PMC), which is a free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health's National Library of Medicine (NIH/NLM).

Downloads last month
32
Edit dataset card